[PS2-7-4] Efficacy and safety of minimum dose tyrosine kinase inhibitor therapy for chronic myeloid leukemia
Abstract password authentication.
Password is written on a program and abstract book.
Poster Session
Sat. Oct, 13
Sat. Oct 13, 2018 5:10 PM - 5:50 PM Poster1 (Osaka International Convention Center, 3F Event Hall)
Chair: Junichiro Yuda (Depart,emt of Hematology, National Cancer Center Hospital East)
Abstract password authentication.
Password is written on a program and abstract book.